IL17A and familial pancreatic carcinoma: IL-17A and IL-17B are primarily involved in the regulation of the tumor immune microenvironment, and they particularly play a special role in the drug resistance and inflammatory response in pancreatic cancer, according to our overview of six different cytokines.